OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $168,223 | -74.9% | 53,574 | -58.8% | 0.00% | – |
| Q2 2023 | $670,547 | +9863.6% | 129,951 | +10076.3% | 0.00% | – |
| Q1 2023 | $6,730 | +87.6% | 1,277 | 0.0% | 0.00% | – |
| Q4 2022 | $3,588 | -10.3% | 1,277 | +27.7% | 0.00% | – |
| Q3 2022 | $4,000 | -99.7% | 1,000 | -99.7% | 0.00% | -100.0% |
| Q2 2022 | $1,376,000 | +695.4% | 342,228 | +881.0% | 0.00% | – |
| Q1 2022 | $173,000 | -73.8% | 34,884 | -63.2% | 0.00% | – |
| Q4 2021 | $661,000 | -79.8% | 94,890 | -70.9% | 0.00% | -100.0% |
| Q3 2021 | $3,266,000 | -60.6% | 326,628 | -44.1% | 0.00% | -66.7% |
| Q2 2021 | $8,293,000 | -8.3% | 584,793 | +6.2% | 0.00% | 0.0% |
| Q1 2021 | $9,039,000 | -29.6% | 550,864 | -11.2% | 0.00% | -25.0% |
| Q4 2020 | $12,836,000 | +1133.0% | 620,096 | +353.5% | 0.00% | – |
| Q3 2020 | $1,041,000 | -24.1% | 136,749 | -16.9% | 0.00% | -100.0% |
| Q2 2020 | $1,371,000 | +741.1% | 164,596 | +400.4% | 0.00% | – |
| Q1 2020 | $163,000 | -21.6% | 32,890 | -37.6% | 0.00% | – |
| Q4 2019 | $208,000 | +163.3% | 52,695 | +103.6% | 0.00% | – |
| Q3 2019 | $79,000 | +3850.0% | 25,883 | +5076.6% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | -75.0% | 500 | -74.0% | 0.00% | – |
| Q4 2018 | $8,000 | -92.5% | 1,923 | -87.6% | 0.00% | – |
| Q3 2018 | $107,000 | -49.3% | 15,536 | -50.3% | 0.00% | – |
| Q2 2018 | $211,000 | +330.6% | 31,270 | +316.9% | 0.00% | – |
| Q1 2018 | $49,000 | +88.5% | 7,500 | +26.2% | 0.00% | – |
| Q4 2017 | $26,000 | -49.0% | 5,942 | -27.4% | 0.00% | – |
| Q3 2017 | $51,000 | +6.2% | 8,185 | +58.9% | 0.00% | – |
| Q2 2017 | $48,000 | -31.4% | 5,150 | -31.8% | 0.00% | – |
| Q1 2017 | $70,000 | +150.0% | 7,556 | +128.1% | 0.00% | – |
| Q4 2016 | $28,000 | -31.7% | 3,313 | -44.5% | 0.00% | – |
| Q3 2016 | $41,000 | +115.8% | 5,973 | +54.7% | 0.00% | – |
| Q2 2016 | $19,000 | +35.7% | 3,862 | +157.5% | 0.00% | – |
| Q1 2016 | $14,000 | -75.4% | 1,500 | -75.4% | 0.00% | – |
| Q4 2015 | $57,000 | +9.6% | 6,088 | +64.5% | 0.00% | – |
| Q3 2015 | $52,000 | +1200.0% | 3,700 | +2014.3% | 0.00% | – |
| Q2 2015 | $4,000 | -87.9% | 175 | -77.5% | 0.00% | – |
| Q1 2015 | $33,000 | +153.8% | 778 | +38.4% | 0.00% | – |
| Q4 2014 | $13,000 | – | 562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,804,788 | $15,105,000 | 43.34% |
| Versant Venture Management, LLC | 2,215,384 | $8,795,074,000 | 2.90% |
| Opaleye Management Inc. | 1,900,000 | $7,543,000 | 2.09% |
| SV Health Investors, LLC | 628,236 | $2,494,000 | 1.46% |
| Endurant Capital Management LP | 716,124 | $2,843,000 | 1.12% |
| DELTEC ASSET MANAGEMENT LLC | 824,747 | $3,274,000 | 0.72% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $583,000 | 0.08% |
| Jump Trading, LLC | 39,255 | $156,000 | 0.05% |
| Man Group plc | 1,723,456 | $6,842,000 | 0.03% |
| JGP Global Gestao de Recursos Ltda. | 13,880 | $55,000 | 0.02% |